Premaitha Health PLC

Premaitha Health PLC
Stock Exchange London Stock Exchange
EPS
-
Market Cap
GBP44.68 M
Shares Outstanding
386.84 M
Public Float
244.5 M

Profile

Address
Rutherford House
Manchester Greater Manchester M15 6SZ
United Kingdom
Employees -
Website http://premaitha.com/
Updated 09/14/2018
Premaitha Health Plc engages in the manufacture, development and sale of molecular diagnostic products. Its product IONA test, which is marked as non-invasive in vitro diagnostic product for prenatal screening. The company was founded in 2013 and is headquartered in Manchester, the United Kingdom.

Financials

View All
Created with Highcharts 5.0.14Premaitha Health PLCNet Income. Fiscal year is April-March. All values GBP Thousands.4 6644 6644 9334 9337 4477 44712 07612 0767 8597 8592013201420152016201702.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Premaitha Health PLCSales/Revenue. Fiscal year is April-March. All values GBP Thousands.25725762621321322 4522 4523 0783 0782013201420152016201701k2k3k4k

Adam Reynolds
Non-Executive Chairman
Barry Kenneth Hextall
Chief Financial Officer & Director